Mobile

A phase II, unicentre, randomized, double-blind, parallel and placebo-controlled, pilot study to evaluate the efficacy and safety of Somatuline Autogel (60 mg) in patients with active thyroid-associat...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-003937-14

A phase II, unicentre, randomized, double-blind, parallel and placebo-controlled, pilot study to evaluate the efficacy and safety of Somatuline Autogel (60 mg) in patients with active thyroid-associated ophthalmopaty of moderate intensity. Estudio piloto, de fase II, unicéntrico, aleatorizado, a doble ciego, paralelo y controlado con placebo para evaluar la eficacia y seguridad de Somatulina Autogel R (60 mg) en pacientes con oftalmopatía tiroidea activa de intensidad moderada

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the efficacy and safety of 3 doses of Somatuline Autogel (60 mg) in the control of the infiltration and edema of the muscle and retrobulbar connective tissue and in the retraction and contraction of the extraocular musculature in patients with active thyroid-associated ophtalmopathy of moderate intensity.

Critère d'inclusion

  • Active thyroid-associated ophtalmopathy of moderate intensity

Liens